Grant: Fellowship Award - Priority Announcement: Fragile X (SHOPP)
McGill University
$67,500.00
Does atypical sleep architecture underlie neuronal disruption in the Fragile-X brain?
FY 2008-09
Summary
Fragile-X syndrome (FXS) is the most common inherited cause of mental retardation and the most frequent known genetic cause of autism. Individuals affected with FXS show cognitive and social skill deficits as well as unusual stereotypical behaviors such as hand-wringing. A growing body of evidence suggests that people with autism frequently display atypical sleeping architecture. Although, long-term sleep disruption most likely contributes to the pathology of FXS, it has yet to be examined systematically. We propose to investigate the relationship between sleep architecture and changes in the brain activity. Sleep is thought to be the price we have to pay for the intense brain activity that occurs during wakefulness. Moreover, sleep plays an important part in memory formation and in ensuring proper maturation of brain cells. In contrast, the FXS brain exhibits immature brain cells, which are thought to underlie the cognitive problems in FXS. Taken together, this information provides a compelling argument for examining the relationship between sleep and synaptic activity in FXS. Moreover, recent work has shown that, at least in the FXS mouse model, FXS symptoms can be reversed by administration of the MPEP drug. MPEP decreases the activity the mGluR5 receptor protein, which is found on the surface of brain cells and plays an important role in allowing brain cells to communicate with each other. As yet, the effect of MPEP on sleep has yet to be examined, but we expect it to restore proper sleep architecture as well as brain activity. To examine this, we will look at the effect of MPEP on sleep architecture and brain activity using electrical measurements of brain activity as well as video for behavior testing of the FXS mouse model compared to control littermates. Since the FXS brain shows immature brain development, correcting an imbalance in sleep architecture may provide a novel therapeutic approach in rectifying brain disruptions that are the hallmark of FXS.
Department
Program
Fellowship Award - Priority Announcement: Fragile X (SHOPP)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
177141
Name
Fay Anne-Marie L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Fragile X Research Foundation of Canada
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Does atypical sleep architecture underlie neuronal disruption in the Fragile-X brain?
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$67,500
Cihrequipment2
$0
Programname2
Fellowship Award - Priority Announcement: Fragile X (SHOPP)
Keyworddelim
Autism; Cognitive Impairment; Electroencephalography; Fragile-X Syndrome; Glutamate Receptors; Knock-Out Mice Model; Rem Sleep; Slice Electrophysiology; Synapse Maturation; Thalamocortical Synapse
Abstract
Fragile-X syndrome (FXS) is the most common inherited cause of mental retardation and the most frequent known genetic cause of autism. Individuals affected with FXS show cognitive and social skill deficits as well as unusual stereotypical behaviors such as hand-wringing. A growing body of evidence suggests that people with autism frequently display atypical sleeping architecture. Although, long-term sleep disruption most likely contributes to the pathology of FXS, it has yet to be examined systematically. We propose to investigate the relationship between sleep architecture and changes in the brain activity. Sleep is thought to be the price we have to pay for the intense brain activity that occurs during wakefulness. Moreover, sleep plays an important part in memory formation and in ensuring proper maturation of brain cells. In contrast, the FXS brain exhibits immature brain cells, which are thought to underlie the cognitive problems in FXS. Taken together, this information provides a compelling argument for examining the relationship between sleep and synaptic activity in FXS. Moreover, recent work has shown that, at least in the FXS mouse model, FXS symptoms can be reversed by administration of the MPEP drug. MPEP decreases the activity the mGluR5 receptor protein, which is found on the surface of brain cells and plays an important role in allowing brain cells to communicate with each other. As yet, the effect of MPEP on sleep has yet to be examined, but we expect it to restore proper sleep architecture as well as brain activity. To examine this, we will look at the effect of MPEP on sleep architecture and brain activity using electrical measurements of brain activity as well as video for behavior testing of the FXS mouse model compared to control littermates. Since the FXS brain shows immature brain development, correcting an imbalance in sleep architecture may provide a novel therapeutic approach in rectifying brain disruptions that are the hallmark of FXS.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Fay, Anne-Marie L
Approvedterm
3 ans 0 mois
Cihrcontribution2
SPIR~ $67,500~ $0~